Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-08-05

Clinical Trial Update: Hepatocyte Transplantation in Liver Failure [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial investigating hepatocyte transplantation for liver failure (Phase 1/Phase 2) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Liver Failure | Phase 1, Phase 2 | Status: WITHDRAWN